Regen BioPharma, Inc. (RGBP)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
-0.0001 (-20.00%)
Apr 29, 2026, 3:07 PM EST
Regen BioPharma Employees
Regen BioPharma had 1 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$236,561
Profits / Employee
-$1,726,971
Market Cap
120.88K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lipella Pharmaceuticals | 7 |
| Sigyn Therapeutics | 4 |
| CNBX Pharmaceuticals | 1 |
| Synairgen | 34 |
| Actavia Life Sciences | 1 |
| Ocean Biomedical | 7 |
Regen BioPharma News
- 6 months ago - Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc. - Accesswire
- 1 year ago - Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™ - GlobeNewsWire
- 1 year ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time - GlobeNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024 - PRNewsWire